Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients

The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) was reported to be associated with tumor progression and metastasis. The purpose of this study was to evaluate the prognostic value of Pit-1 in breast cancer patients. The relative expression levels of Pit-1 in breast canc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical science monitor 2016-10, Vol.22, p.4121-4125
Hauptverfasser: Gao, Zhongcheng, Xue, Kecheng, Zhang, Lianfang, Wei, Meng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4125
container_issue
container_start_page 4121
container_title Medical science monitor
container_volume 22
creator Gao, Zhongcheng
Xue, Kecheng
Zhang, Lianfang
Wei, Meng
description The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) was reported to be associated with tumor progression and metastasis. The purpose of this study was to evaluate the prognostic value of Pit-1 in breast cancer patients. The relative expression levels of Pit-1 in breast cancer patients were detected by quantitative real-time PCR (qRT-PCR). Chi-square analysis was used to analyze the association between Pit-1 expression and clinical features. The Kaplan-Meier method was used to estimate the overall survival of the patients and Cox regression analysis was used to analyze the prognostic value of Pit-1. Increased expression of Pit-1 was detected in the tumor tissues compared with the normal tissues (1.086 vs. 0.541) and the abnormal expression was associated with tumor size, clinical stage, tumor grade, and lymph node metastasis (P
doi_str_mv 10.12659/MSM.896107
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5094475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834998578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-181c0c80b932e1b72f54d655935b0790aa32ed7052f417d6533fd63bdbc6e2463</originalsourceid><addsrcrecordid>eNpVkcFLwzAUxoMoTqcn75KjItWkaZr2IujYnKCsoDuHNE1npGtmXje2_97oVOYpL-_78b3H-xA6o-SaxinPb55fnq-zPKVE7KEjmiYsYoKT_Z26h44B3gmJs5TwQ9SLhcgzzsUR2kxWxkfD9cIbAOta7GpcTKZ40CgATPHYzY0r3TqUr161oL1ddF_cSOnOeXxR2C6il7jwprK6A1y40C28m7UOLOA6_O69UdDhgWq1CZrqrGk7OEEHtWrAnP68fTQdDV8H4-hp8vA4uHuKNMto8M6oJjojZc5iQ0sR1zypUs5zxksicqJU6FeC8LhOqAgKY3WVsrIqdWriJGV9dLv1XSzLual0mO1VIxfezpXfSKes_K-09k3O3EpykieJ4MHg4sfAu4-lgU7OLWjTNKo1bgmSZizJwzlFFtCrLaq9A_Cm_htDifwOS4aw5DasQJ_vbvbH_qbDPgEGNI_C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834998578</pqid></control><display><type>article</type><title>Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Gao, Zhongcheng ; Xue, Kecheng ; Zhang, Lianfang ; Wei, Meng</creator><creatorcontrib>Gao, Zhongcheng ; Xue, Kecheng ; Zhang, Lianfang ; Wei, Meng</creatorcontrib><description>The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) was reported to be associated with tumor progression and metastasis. The purpose of this study was to evaluate the prognostic value of Pit-1 in breast cancer patients. The relative expression levels of Pit-1 in breast cancer patients were detected by quantitative real-time PCR (qRT-PCR). Chi-square analysis was used to analyze the association between Pit-1 expression and clinical features. The Kaplan-Meier method was used to estimate the overall survival of the patients and Cox regression analysis was used to analyze the prognostic value of Pit-1. Increased expression of Pit-1 was detected in the tumor tissues compared with the normal tissues (1.086 vs. 0.541) and the abnormal expression was associated with tumor size, clinical stage, tumor grade, and lymph node metastasis (P&lt;0.05). High expression level of Pit-1 was significantly associated with poor overall survival of the patients (P=0.001) and Cox regression analysis indicated that Pit-1 might be a prognostic factor for breast cancer prognosis (HR=1.955, 95% CI=1.295-3.035, P=0.003). Pit-1 may be a potential prognostic biomarker for breast cancer patients and it is associated with tumor progression.</description><identifier>ISSN: 1643-3750</identifier><identifier>ISSN: 1234-1010</identifier><identifier>EISSN: 1643-3750</identifier><identifier>DOI: 10.12659/MSM.896107</identifier><identifier>PMID: 27798557</identifier><language>eng</language><publisher>United States: International Scientific Literature, Inc</publisher><subject>Adult ; Aged ; Biomarkers, Tumor - biosynthesis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; China ; Clinical Research ; Disease-Free Survival ; Female ; Genes, Homeobox ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Middle Aged ; Predictive Value of Tests ; Prognosis ; RNA, Messenger - metabolism ; Transcription Factor Pit-1 - biosynthesis ; Transcription Factor Pit-1 - genetics ; Transcription Factor Pit-1 - metabolism</subject><ispartof>Medical science monitor, 2016-10, Vol.22, p.4121-4125</ispartof><rights>Med Sci Monit, 2016 2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-181c0c80b932e1b72f54d655935b0790aa32ed7052f417d6533fd63bdbc6e2463</citedby><cites>FETCH-LOGICAL-c381t-181c0c80b932e1b72f54d655935b0790aa32ed7052f417d6533fd63bdbc6e2463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094475/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094475/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27798557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Zhongcheng</creatorcontrib><creatorcontrib>Xue, Kecheng</creatorcontrib><creatorcontrib>Zhang, Lianfang</creatorcontrib><creatorcontrib>Wei, Meng</creatorcontrib><title>Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients</title><title>Medical science monitor</title><addtitle>Med Sci Monit</addtitle><description>The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) was reported to be associated with tumor progression and metastasis. The purpose of this study was to evaluate the prognostic value of Pit-1 in breast cancer patients. The relative expression levels of Pit-1 in breast cancer patients were detected by quantitative real-time PCR (qRT-PCR). Chi-square analysis was used to analyze the association between Pit-1 expression and clinical features. The Kaplan-Meier method was used to estimate the overall survival of the patients and Cox regression analysis was used to analyze the prognostic value of Pit-1. Increased expression of Pit-1 was detected in the tumor tissues compared with the normal tissues (1.086 vs. 0.541) and the abnormal expression was associated with tumor size, clinical stage, tumor grade, and lymph node metastasis (P&lt;0.05). High expression level of Pit-1 was significantly associated with poor overall survival of the patients (P=0.001) and Cox regression analysis indicated that Pit-1 might be a prognostic factor for breast cancer prognosis (HR=1.955, 95% CI=1.295-3.035, P=0.003). Pit-1 may be a potential prognostic biomarker for breast cancer patients and it is associated with tumor progression.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - biosynthesis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>China</subject><subject>Clinical Research</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Genes, Homeobox</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphatic Metastasis</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>RNA, Messenger - metabolism</subject><subject>Transcription Factor Pit-1 - biosynthesis</subject><subject>Transcription Factor Pit-1 - genetics</subject><subject>Transcription Factor Pit-1 - metabolism</subject><issn>1643-3750</issn><issn>1234-1010</issn><issn>1643-3750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkcFLwzAUxoMoTqcn75KjItWkaZr2IujYnKCsoDuHNE1npGtmXje2_97oVOYpL-_78b3H-xA6o-SaxinPb55fnq-zPKVE7KEjmiYsYoKT_Z26h44B3gmJs5TwQ9SLhcgzzsUR2kxWxkfD9cIbAOta7GpcTKZ40CgATPHYzY0r3TqUr161oL1ddF_cSOnOeXxR2C6il7jwprK6A1y40C28m7UOLOA6_O69UdDhgWq1CZrqrGk7OEEHtWrAnP68fTQdDV8H4-hp8vA4uHuKNMto8M6oJjojZc5iQ0sR1zypUs5zxksicqJU6FeC8LhOqAgKY3WVsrIqdWriJGV9dLv1XSzLual0mO1VIxfezpXfSKes_K-09k3O3EpykieJ4MHg4sfAu4-lgU7OLWjTNKo1bgmSZizJwzlFFtCrLaq9A_Cm_htDifwOS4aw5DasQJ_vbvbH_qbDPgEGNI_C</recordid><startdate>20161031</startdate><enddate>20161031</enddate><creator>Gao, Zhongcheng</creator><creator>Xue, Kecheng</creator><creator>Zhang, Lianfang</creator><creator>Wei, Meng</creator><general>International Scientific Literature, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161031</creationdate><title>Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients</title><author>Gao, Zhongcheng ; Xue, Kecheng ; Zhang, Lianfang ; Wei, Meng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-181c0c80b932e1b72f54d655935b0790aa32ed7052f417d6533fd63bdbc6e2463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - biosynthesis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>China</topic><topic>Clinical Research</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Genes, Homeobox</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphatic Metastasis</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>RNA, Messenger - metabolism</topic><topic>Transcription Factor Pit-1 - biosynthesis</topic><topic>Transcription Factor Pit-1 - genetics</topic><topic>Transcription Factor Pit-1 - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Gao, Zhongcheng</creatorcontrib><creatorcontrib>Xue, Kecheng</creatorcontrib><creatorcontrib>Zhang, Lianfang</creatorcontrib><creatorcontrib>Wei, Meng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical science monitor</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Zhongcheng</au><au>Xue, Kecheng</au><au>Zhang, Lianfang</au><au>Wei, Meng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients</atitle><jtitle>Medical science monitor</jtitle><addtitle>Med Sci Monit</addtitle><date>2016-10-31</date><risdate>2016</risdate><volume>22</volume><spage>4121</spage><epage>4125</epage><pages>4121-4125</pages><issn>1643-3750</issn><issn>1234-1010</issn><eissn>1643-3750</eissn><abstract>The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) was reported to be associated with tumor progression and metastasis. The purpose of this study was to evaluate the prognostic value of Pit-1 in breast cancer patients. The relative expression levels of Pit-1 in breast cancer patients were detected by quantitative real-time PCR (qRT-PCR). Chi-square analysis was used to analyze the association between Pit-1 expression and clinical features. The Kaplan-Meier method was used to estimate the overall survival of the patients and Cox regression analysis was used to analyze the prognostic value of Pit-1. Increased expression of Pit-1 was detected in the tumor tissues compared with the normal tissues (1.086 vs. 0.541) and the abnormal expression was associated with tumor size, clinical stage, tumor grade, and lymph node metastasis (P&lt;0.05). High expression level of Pit-1 was significantly associated with poor overall survival of the patients (P=0.001) and Cox regression analysis indicated that Pit-1 might be a prognostic factor for breast cancer prognosis (HR=1.955, 95% CI=1.295-3.035, P=0.003). Pit-1 may be a potential prognostic biomarker for breast cancer patients and it is associated with tumor progression.</abstract><cop>United States</cop><pub>International Scientific Literature, Inc</pub><pmid>27798557</pmid><doi>10.12659/MSM.896107</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1643-3750
ispartof Medical science monitor, 2016-10, Vol.22, p.4121-4125
issn 1643-3750
1234-1010
1643-3750
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5094475
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Adult
Aged
Biomarkers, Tumor - biosynthesis
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
China
Clinical Research
Disease-Free Survival
Female
Genes, Homeobox
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis
Middle Aged
Predictive Value of Tests
Prognosis
RNA, Messenger - metabolism
Transcription Factor Pit-1 - biosynthesis
Transcription Factor Pit-1 - genetics
Transcription Factor Pit-1 - metabolism
title Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Over-Expression%20of%20POU%20Class%201%20Homeobox%201%20Transcription%20Factor%20(Pit-1)%20Predicts%20Poor%20Prognosis%20for%20Breast%20Cancer%20Patients&rft.jtitle=Medical%20science%20monitor&rft.au=Gao,%20Zhongcheng&rft.date=2016-10-31&rft.volume=22&rft.spage=4121&rft.epage=4125&rft.pages=4121-4125&rft.issn=1643-3750&rft.eissn=1643-3750&rft_id=info:doi/10.12659/MSM.896107&rft_dat=%3Cproquest_pubme%3E1834998578%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834998578&rft_id=info:pmid/27798557&rfr_iscdi=true